Fludarabine, Cyclophosphamide, and Antithymocyte Globulin for a Patient with Dyskeratosis Congenita and Severe Bone Marrow Failure

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 3, 2007, Pages 366-368

  Ostronoff, Fabiana ^a   Ostronoff, Mauricio ^a   Calixto, Rodolfo ^a   Florêncio, Rodrigo ^a   Domingues, Mariana C ^a   Souto Maior, Ana Patricia ^a   Sucupira, Alexandre ^a   Tagliari, Clemente ^a  

^a Real Hospital Portugues   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; HEMOGLOBIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHENYTOIN; THYMOCYTE ANTIBODY;

ALLOGENEIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; BONE MARROW BIOPSY; BONE MARROW DEPRESSION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; DYSKERATOSIS CONGENITA; FATALITY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; LETTER; LEUKOCYTE COUNT; LEUKOPLAKIA; PRESCHOOL CHILD; REDUCED INTENSITY CONDITIONING; SEIZURE; TANDEM REPEAT; THROMBOCYTE COUNT;

ANTILYMPHOCYTE SERUM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW DISEASES; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DYSKERATOSIS CONGENITA; FEMALE; HUMANS; VIDARABINE;

EID: 33847054310     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.11.015     Document Type: Letter

References (23)

1. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol 110 (2000) 768-779
2. Bagby G.C., Lipton J.M., Sloand E.M., et al. Marrow failure. Hematology (2004) 318-336
3. Langston A.A., Sanders J.E., Deeg H.J., et al. Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita. Br J Haematol 92 (1996) 758-765
4. Rocha V., Devergie A., Socie G., et al. Unusual complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol 103 (1998) 243-248
5. Yabe M., Yabe H., Hattori K., et al. Fatal interstitial pulmonary disease in a patient with dyskeratosis congenital after allogeneic bone marrow transplantation. Bone Marrow Transplant 19 (1997) 389-392
6. Knight S., Vulliamy T., Copplestone A., et al. Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol 103 (1998) 990-996
7. Ghavamzadeh A., Alimoghadam K., Nasseri P., et al. Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation. Bone Marrow Transplant 23 (1999) 299-301
8. Nobili B., Rossi G., De Stefano P., et al. Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen. Br J Haematol 119 (2002) 573-574
9. Güngör T., Corbacioglu S., Storb R., et al. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of dyskeratosis congenita. Bone Marrow Transplant 31 (2003) 407-410
10. Dror Y., Freedman M.H., Leaker M., et al. Low-intensity hematopoietic stem-cell transplantation across human leukocyte antigen barriers in dyskeratosis congenita. Bone Marrow Transplant 31 (2003) 847-850
11. Ayas M., Al-Musa A., Al-Jefri A., et al. Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low-dose cyclophosphamide and antithymocyte globulin. Pediatr Blood Cancer (2005) [Epub ahead of print]
12. Marsh J.C., Ball S.E., Darbyshire P., et al., British Committee for Standards in Haematology. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 123 (2003) 782-801
13. Wynn R., Thornley I., Freedman M., et al. Telomere shortening in leucocyte subsets of long-term survivors of allogeneic bone marrow transplantation. Br J Haematol 105 (1999) 997-1001
14. Bacigalupo A. Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects. Bone Marrow Transplant 35 (2005) 225-231
15. Bacigalupo A., Lamparelli T., Bruzzi P., et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood 98 (2001) 2942-2947
16. Mahmoud H.K., Schaefer U.W., Schmidt C.G., et al. Marrow transplantation for pancytopenia in dyskeratosis congenita. Blut 51 (1985) 57-60
17. Conter V., Johnson E.L., Paolucci P., et al. Bone marrow transplantation for severe aplastic anemia associated with dyskeratosis congenita. Am J Pediatr Hematol Oncol 10 (1988) 99-102
18. Lau Y.L., Ha S.Y., Chan C.F., et al. Bone marrow transplant for dyskeratosis congenita. Br J Haematol 105 (1999) 571
19. Shaw P.H., Haut P.R., Olszewski M., et al. Hematopoietic stem-cell transplantation using unrelated cord-blood versus matched sibling marrow in pediatric bone marrow failure syndrome: one center's experience. Pediatr Transplant 3 (1999) 315-321
20. Brazzola P., Duval M., Fournet J.C., et al. Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite a low-intensity conditioning regimen. Bone Marrow Transplant 36 (2005) 1103-1105
21. Berthou C., Devergie A., D'Agay M.F., et al. Late vascular complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol 79 (1991) 335-336
22. Treister N., Lehmann L.E., Cherrick I., et al. Dyskeratosis congenita vs chronic graft-versus-host disease: report of a case and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (2004) 566-571
23. Bacigalupo A., Locatelli F., Lanino E., et al., Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Fludarabine, cyclophosphamide and antithymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant 36 (2005) 947-950